Advances in Prognostic Methylation Biomarkers for Prostate Cancer

There is a major clinical need for accurate biomarkers for prostate cancer prognosis, to better inform treatment strategies and disease monitoring. Current clinically recognised prognostic factors, including prostate-specific antigen (PSA) levels, lack sensitivity and specificity in distinguishing a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Dilys Lam, Susan Clark, Clare Stirzaker, Ruth Pidsley
Materialtyp: Artigo
Språk:Inglês
Publicerad: MDPI AG 2020-10-01
Serie:Cancers
Ämnen:
DNA methylation
epigenetics
biomarkers
circulating DNA
cfDNA
prostate cancer
Länkar:https://www.mdpi.com/2072-6694/12/10/2993
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk